In this plenary session at World Vaccine Congress Washington, panelists will discuss how to incorporate innovation into vaccine clinical trials, including:
Beth-Ann Coller, Executive Director, Global Clinical Development – Vaccines, Merck
- Claudia Christian, Vice President, Global Clinical Operations , FHI Clinical
- Jeff Roberts, Associate Director, Scientific Affairs, Office of Vaccines, FDA
- Dr Todd Wilson, Director, Early Clinical Development, GSK Vaccines
FHI Clinical Panelist
With more than 25 years of experience, Claudia Christian has held positions in pharmaceutical, biotech and CRO industries across multiple indications. Since 2014, she has devoted her expertise full-time to infectious disease research, including managing multiple study protocols and developing sites across West Africa during the Ebola outbreak response. Since that time, she has managed millions of dollars in federally and privately funded grants as well as commercially funded vaccine and other therapeutic studies.
As Senior Vice President, Clinical Operations, Claudia leads the overall direction and strategic implementation of program execution for all clinical research activities at FHI Clinical.
Claudia holds a bachelor’s degree in Biology from Trinity College-Hartford and a master’s certification in Education from Saint Joseph College.